Study of Postprandial Lipaemia in Type 2 Diabetes Mellitus: Exenatide versus Liraglutide

Table 2

Baseline measurements of the study subjects stratified according to treatment.

Characteristics	Exenatide (𝑛=10)	Liraglutide (𝑛=10)	𝑃
Glucose (mg/dL)	7.34±2.73	6.69±0.94	0.971
Total cholesterol (mg/dL)	5.05±1.42	5.15±1.19	0.853
Triglycerides (mg/dL)	3.03±4.69	2.42±2.97	0.853
HDL (mg/dL)	1.03±0.33	1.19±0.45	0.481
LDL (mg/dL)	3.00±1.26	2.87±0.71	1.000
Insulin (mU/L)	159.86±84.58	152.07±49.74	0.739

Data are means ± SD. (𝑃 indicates the result of the Mann-Whitney test between the two groups).